Skip to content

Drug Order for Rapid Sequence Intubation

Drug Order for Rapid Sequence Intubation in Emergency Department Intubation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03420950
Acronym
DO-RSI
Enrollment
335
Registered
2018-02-05
Start date
2018-02-05
Completion date
2021-09-29
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Brief summary

This is a randomized, blinded trial comparing the order of drug administration for rapid sequence intubation in the Emergency Department.

Detailed description

Based on data (excluding outliers) from protocol 16-4146, the intubation time with the paralytic and sedative first administered is 86 s, and 93 s, respectively, with a standard deviation of approximately 25-30 s. Using these assumptions, 470 patients (235 per group) will need to be enrolled to detect an 7 s absolute difference between groups with 80% power. Because a greater difference is anticipated in those who receive rocuronium rather than succinylcholine (because succinylcholine takes action faster), goal enrollment is 470 patients who receive rocuronium as the paralytic who are intubated successfully on the first attempt. The total enrollment will be higher, accounting for those who receive succinylcholine and those who are not successful on the first attempt. The data for those who receive succinylcholine first will be reported and is planned to be used to determine the feasibility of a future trial. The primary group of analysis will be those receiving rocuronium, because this medication acts somewhat slower than succinylcholine. Patients who receive either drug will be analyzed, but it is pre-specified that the group of interest are those receiving rocuronium. The primary outcome, first intubation attempt duration, and apnea duration will be measured only in those with a successful first attempt because these timing events will be confounded by attempt failure; in these cases the altered duration will have more to do with device or patient characteristics than with drug order. The remainder of the outcomes will be measured in all enrolled subjects in an intention to treat analysis. An analysis for patients by RSI drug order actually received, regardless of treatment allocation, will also be presented.

Interventions

OTHERRapid sequence intubation: sedative first

Sedative first

OTHERRapid sequence intubation: paralytic first

Paralytic first

Sponsors

Hennepin Healthcare Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The nurse administering the drug is not blinded, but the outcome assessor and physician performing the intubation are blinded to drug order.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must be undergoing orotracheal intubation in the Emergency Department * The patient must be receiving both a sedative and paralytic immediately prior to intubation (i.e. undergoing rapid sequence intubation). * The patient must be presumed to be 18 years of age or older at the time of enrollment.

Exclusion criteria

* Prisoner or in custody * Known or suspected to be pregnant, based on the opinion of the attending physician. * Intubation performed by a physician assistant (this is rarely done in our ED; each physician assistant intubates less than twice per year, so the intubation outcomes would hinge more on their experience rather than drug order).

Design outcomes

Primary

MeasureTime frameDescription
Time elapsed from drug administration to intubation attempt end5 minutesThe primary outcome will be time from complete administration of the first medication to successful first attempt intubation. This timing period will begin when the first RSI agent is completely administered and end when the laryngoscope blade is removed from the mouth. Attempts that are not successful on the first attempt will be excluded from the primary outcome measure because the time to intubation will be confounded by the failure; in these cases the altered duration will have more to do with device or patient characteristics than with drug order.

Secondary

MeasureTime frameDescription
Duration of first intubation attempt5 minutesDefined as the time elapsed between inserting and removing the laryngoscope blade from the mouth. The primary outcome, duration of the first intubation attempt, and apnea duration will only be measured in those with a successful first attempt.
Hypoxemia5 minutesOxygen saturation \< 90%, during the time interval between the start of the intubation attempt and 1 minute following completion of the attempt.
Best laryngeal view5 minutesCormack-Lehane grade
First intubation attempt success5 minutesDefined as successful intubation with a single insertion of the laryngoscope, regardless of the number of passages of the endotracheal tube or bougie.

Other

MeasureTime frameDescription
Memory of intubation1 week (approximately)A structured questionnaire will be administered to patients after extubation. We will attempt to approach all enrolled patients, but realize that some will be unreachable due to death, head injury, rapid discharge from the hospital, and other reason.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026